Wayne T. Pan

Medical Director-Medical Sciences at BioMarin Pharmaceutical, Inc.

Wayne T. Pan

Wayne T. Pan

Medical Director-Medical Sciences at BioMarin Pharmaceutical, Inc.

Overview

RelSci Relationships

2184

Number of Boards

1

Birthday

1963

Age

57

Relationships

View Relationship Details

RelSci Relationships are individuals Wayne T. Pan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Herbert J. Semler

Co-Founder at Semler Scientific, Inc.

Relationship likelihood: Strong

Shirley L. Semler

Co-Founder at Semler Scientific, Inc.

Relationship likelihood: Strong

Douglas R. Murphy-Chutorian

Chief Executive Officer, Secretary & Director at Semler Scientific, Inc.

Relationship likelihood: Strong

Jean-Jacques Bienaimé

Chief Executive Officer & President at BioMarin Pharmaceutical, Inc.

Relationship likelihood: Strong

Bruce J. Barclay

Officer & Senior Vice President at Guidant Sales Corp.

Relationship likelihood: Strong

Arthur N. Leibowitz

Co-Founder at Health Advocate, Inc.

Relationship likelihood: Strong

Gregory S. Garfield

Senior Managing Director at KCK Group LLC

Relationship likelihood: Strong

Aidan Collins

Managing Director at CBIZ, Inc.

Relationship likelihood: Strong

William Chang

Founding Governor at The City Club of San Francisco, Inc.

Relationship likelihood: Strong

Dinesh C. Gupta

General Partner at First Guardian Group I LLC

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

PR Newswire

May 14, 2014

Semler Scientific, Inc. Appoints Healthcare Technology Expert Wayne T. Pan, M.D., Ph.D., to its Board of Directors

Paths to Wayne T. Pan

Potential Connections via
Relationship Science

You

Wayne T. Pan

Medical Director-Medical Sciences at BioMarin Pharmaceutical, Inc.

Education

University of Pennsylvania - The Wharton School

The Wharton School is the business school of the University of Pennsylvania, an Ivy League university in Philadelphia, Pennsylvania. Wharton was the world’s first collegiate business school and the first business school in the United States. It was established in 1881 through a donation of Joseph Wharton.

Johns Hopkins University

To educate students, to foster independent & original research, and to share benefits discovered.

Icahn School of Medicine at Mount Sinai

The School commits to dramatically advancing the art and science of medical care through an atmosphere of intense collaborative learning, social concern, and scholarly inquiry.

Career History

Medical Director-Medical Sciences

2018 - Current

BioMarin Pharmaceutical, Inc.

About BioMarin BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; KUVAN® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase III clinical development for the treatment of MPS IVA, PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU, BMN-701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase (IGF2-GAA), which is currently in Phase I/II clinical development for the treatment of Pompe disease, and BMN-673, a poly ADP-ribose polymerase (PARP) inhibitor, which is currently in Phase I/II clinical development for the treatment of genetically-defined cancers and BMN-111, a modified C-natriuretic peptide, which is currently in Phase I clinical development for the treatment of achondroplasia.

Medical Director-Quality Care & Health Economics

2016 - 2018

Genentech, Inc.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Medical Director

2014 - 2015

Clover Health Labs LLC

Other Affiliations

Wayne T. Pan is affiliated with BioMarin Pharmaceutical, Inc., Genentech, Inc., Clover Health Labs LLC, Santa Clara County Individual Practice Association, Thrasys, Inc., Alameda Alliance for Health, Pacific Partners Management Services, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Wayne T. Pan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Wayne T. Pan's profile does not indicate a business or promotional relationship of any kind between RelSci and Wayne T. Pan.